Literature DB >> 16259349

Allopurinol-induced DRESS syndrome.

Arie Markel1.   

Abstract

Hyperuricemia is present in approximately 5% of the population, the vast majority of whom are asymptomatic and at no clinical risk. Complications, including renal calculi, uric acid nephropathy and gout, occur in a small proportion of patients. Allopurinol, an analog of hypoxanthine, has been widely used in clinical practice for over 30 years for the treatment of hyperuricemia and gout. Two percent of patients taking this medication develop a mild exanthema. A syndrome characterized by exfoliative dermatitis, hepatitis, interstitial nephritis and eosinophilia has been described previously. Termed allopurinol hypersensitivity syndrome, its etiology is related to the accumulation of one of the allopurinol metabolites, oxypurinol; clearance of oxypurinol is decreased in the setting of renal insufficiency and the use of thiazide diuretics. The term DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms) was recently introduced to describe a disorder associated with various drugs or viral infections and characterized by similar features. The pathophysiology of allopurinol-induced hypersensitivity, clinical presentation and treatment are reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259349

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  10 in total

1.  [Allopurinol-induced hypersensitivity syndrome resulting in death].

Authors:  Sören Laurisch; Maren Jaedtke; Reyhan Demir; Sajoscha A Sorrentino; Jan T Kielstein; Hans-Oliver Rennekampff; Peter M Vogt; Gerd P Meyer; Martin Fuchs; Gunnar Klein; Hartmut Drexler; Bernhard Schieffer; L Christian Napp
Journal:  Med Klin (Munich)       Date:  2010-04

2.  Allopurinol-induced DRESS syndrome.

Authors:  Selcuk Yaylacı; Mustafa Volkan Demir; Tayfun Temiz; Ali Tamer; Mustafa Ihsan Uslan
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

Review 3.  Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

Authors:  Ratchadaporn Somkrua; Elizabeth E Eickman; Surasak Saokaew; Manupat Lohitnavy; Nathorn Chaiyakunapruk
Journal:  BMC Med Genet       Date:  2011-09-09       Impact factor: 2.103

4.  New and improved strategies for the treatment of gout.

Authors:  Natalie Dubchak; Gerald F Falasca
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-24

5.  Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study.

Authors:  Tai-Ming Ko; Chang-Youh Tsai; Shih-Yang Chen; Kuo-Shu Chen; Kuang-Hui Yu; Chih-Sheng Chu; Chung-Ming Huang; Chrong-Reen Wang; Chia-Tse Weng; Chia-Li Yu; Song-Chou Hsieh; Jer-Chia Tsai; Wen-Ter Lai; Wen-Chan Tsai; Guang-Dar Yin; Tsan-Teng Ou; Kai-Hung Cheng; Jeng-Hsien Yen; Teh-Ling Liou; Tsung-Hsien Lin; Der-Yuan Chen; Pi-Jung Hsiao; Meng-Yu Weng; Yi-Ming Chen; Chen-Hung Chen; Ming-Fei Liu; Hsueh-Wei Yen; Jia-Jung Lee; Mei-Chuan Kuo; Chen-Ching Wu; Shih-Yuan Hung; Shue-Fen Luo; Ya-Hui Yang; Hui-Ping Chuang; Yi-Chun Chou; Hung-Ting Liao; Chia-Wen Wang; Chun-Lin Huang; Chia-Shuo Chang; Ming-Ta Michael Lee; Pei Chen; Chih-Shung Wong; Chien-Hsiun Chen; Jer-Yuarn Wu; Yuan-Tsong Chen; Chen-Yang Shen
Journal:  BMJ       Date:  2015-09-23

6.  Allopurinol-induced DRESS syndrome mimicking biliary obstruction.

Authors:  Hyung Gyu Choi; Junsu Byun; Chae Ho Moon; Jong Ho Yoon; Ki Young Yang; Su Cheol Park; Chul Ju Han
Journal:  Clin Mol Hepatol       Date:  2014-03-26

7.  Skin rash, eosinophilia, and renal impairment in a patient recently started on allopurinol.

Authors:  Ashraf Jmeian; Amer Hawatmeh; Razan Shamoon; Fayez Shamoon; Michael Guma
Journal:  J Family Med Prim Care       Date:  2016 Apr-Jun

Review 8.  Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat.

Authors:  Andreas Jordan; Ursula Gresser
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-25

9.  Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate.

Authors:  P Cacoub; V Descamps; O Meyer; C Speirs; P Belissa-Mathiot; P Musette
Journal:  Osteoporos Int       Date:  2013-01-30       Impact factor: 5.071

10.  Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Due to Anti-TB Medication.

Authors:  Dharmesh H Kaswala
Journal:  J Family Med Prim Care       Date:  2013-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.